The effects of exogenous l-carnitine on lipid peroxidation and tissue damage in an experimental warm hepatic ischemia-reperfusion injury model

Current Therapeutic Research - Clinical and Experimental

Volumn 68, Issue 1, 2007, Pages 32-46

  Canbaz, Hakan ^a   Akca, Tamer ^a   Tataroglu, Canten ^b   Caglikulekci, Mehmet ^a   Dirlik, Musa ^a   Ayaz, Lokman ^a   Ustunsoy, Ali Bora ^a   Tasdelen, Bahar ^a   Aydin, Suha ^a  

^a MERSIN UNIVERSITY   (Turkey)

^b ADNAN MENDERES UNIVERSITY   (Turkey)

Author keywords

experimental; ischemia; l carnitine; liver; reperfusion

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CARNITINE; MALONALDEHYDE; MYELOPEROXIDASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD SAMPLING; CONTROLLED STUDY; DRUG EFFECT; HISTOPATHOLOGY; LEUKOCYTE; LIPID PEROXIDATION; LIVER INJURY; LIVER ISCHEMIA; LIVER PERFUSION; LIVER PROTECTION; LIVER RESECTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE; TISSUE INJURY;

EID: 34547611310     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.curtheres.2007.02.002     Document Type: Article

References (34)

1. Teoh N., and Farrell G. Hepatic ischemia reperfusion injury: Pathogenic mechanisms and basis for hepatoprotection. J Gastroenterol Hepatol 18 (2003) 891-902
2. Paulson D., and Shug A. Experimental evidence of the anti-ischemic effect of l-carnitine. In: de Jong J., and Ferrari R. (Eds). The Carnitine System: A New Therapeutical Approach to Cardiovascular Diseases. 1st ed. (1995), Kluwer Academic Publishers, Dordrecht, The Netherlands 183-197
3. Jaeschke H. Role of reactive oxygen species in hepatic ischemia-reperfusion injury and preconditioning. J Invest Surg 16 (2003) 127-140
4. Yonezawa K., Tolba R., Wetter A., et al. l-carnitine could not improve hepatic warm ischemia-reperfusion injury despite ameliorated blood flow. J Surg Res 125 (2005) 16-22
5. Atila K., Coker A., Sagol O., et al. Protective effects of carnitine in an experimental ischemia-reperfusion injury. Clin Nutr 21 (2002) 309-313
6. Puetz U., Tolba R., Akbar S., et al. Effects of l-carnitine-hydrochloride in the cold ischemic preservation of fatty liver grafts. Transplant Proc 33 (2001) 2523-2524
7. Akar H., Sarac A., Konuralp C., et al. Comparison of histopathologic effects of carnitine and ascorbic acid on reperfusion injury. Eur J Cardiothorac Surg 19 (2001) 500-506
8. Vanella A., Russo A., Acquaviva R., et al. l-propionyl-carnitine as superoxide scavenger, antioxidant, and DNA cleavage protector. Cell Biol Toxicol 16 (2000) 99-104
9. Mister M., Noris M., Szymczuk J., et al. Propionyl-l-carnitine prevents renal function deterioration due to ischemia/reperfusion. Kidney Int 61 (2002) 1064-1078
10. Akgun S., Tekeli A., Kurtkaya O., et al. Neuroprotective effects of FK-506, l-carnitine and azathioprine on spinal cord ischemia-reperfusion injury. Eur J Cardiothorac Surg 25 (2004) 105-110
11. Tellioglu A., Uras K., Yilmaz T., et al. The effect of carnitine on random-pattern flap survival in rats. Plast Reconstr Surg 108 (2001) 959-962
12. http://www.cevreorman.gov.tr/yasa/k/25509.doc
13. World Medical Association (WMA) statement on animal use in biomedical research [WMA Web site] (1989), WMA, Hong Kong Available at: http://www.wma.net/e/policy/a18.htm. Accessed July 18, 2006.
14. Yagi K. Lipid peroxides and related radicals in clinical medicine. In: Armstrong D. (Ed). Free Radicals in Diagnostic Medicine (1994), Plenum Press, New York, NY 1-15
15. In: Colowick S., and Kaplan N. (Eds). Methods in Enzymology (1955), Academic Press Inc, New York, NY 769
16. Miller N., Rice-Evans C., Davies M., et al. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci (Lond) 84 (1993) 407-412
17. Rosai J. Special techniques in surgical pathology. In: Rosai J. (Ed). Ackerman's Surgical Pathology. 8th ed. (1996), Mosby, St Louis, Mo 29-62
18. Bismuth H., and Fecteau A. Hepatobiliary surgery. In: Bacon B., and Di Bisceglie A. (Eds). Liver Disease: Diagnosis and Management. 1st ed. (2000), Churchill Livingstone, Philadelphia, Pa 370-382
19. Lentsch A., Kato A., Yoshidome H., et al. Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/reperfusion injury. Hepatology 32 (2000) 169-173
20. Marubayashi S., Dohi K., Ochi K., and Kawasaki T. Role of free radicals in ischemic rat liver cell injury: Prevention of damage by alpha-tocopherol administration. Surgery 99 (1986) 184-192
21. Marubayashi S., Dohi K., Yamada K., and Kawasaki T. Changes in the levels of endogenous coenzyme Q homologs, alpha-tocopherol, glutathione in rat liver after hepatic ischemia and reperfusion, and the effect of pretreatment with coenzyme Q10. Biochim Biophys Acta 797 (1984) 1-9
22. Serracino-Inglott F., Habib N., and Mathie R. Hepatic ischemia-reperfusion injury. Am J Surg 181 (2001) 160-166
23. Jaeschke H. Reactive oxygen and ischemia/reperfusion injury of the liver. Chem Biol Interact 79 (1991) 115-136
24. Kobayashi T., Esato K., Morita N., and Noshima N. Effects of thromboxane A2 synthesis inhibitor (OKY-046) on total liver ischemia in rats. Int Surg 81 (1996) 115-118
25. Koster J. Free radical-mediated damage and carnitine esters. In: de Jong J., and Ferrari R. (Eds). The Carnitine System: A New Therapeutical Approach to Cardiovascular Diseases. 1st ed (1995), Kluwer Academic Publishers, Dordrecht, The Netherlands 123-132
26. Liu Z., Xu Z., Shen W., et al. Effect of pharmacologic preconditioning with tetrandrine on subsequent ischemia/reperfusion injury in rat liver. World J Surg 28 (2004) 620-624
27. Tselepidis S., Papazoglou L., Dessiris A., et al. Liver injury after ischemia and reperfusion: The role of oxygen free radicals. Mil Med 169 (2004) 531-535
28. Su J., Guo C., Wei J., et al. Protection against hepatic ischemia-reperfusion injury in rats by oral pretreatment with quercetin. Biomed Environ Sci 16 (2003) 1-8
29. Demirdag K., Bahcecioglu I., Ozercan I., et al. Role of l-carnitine in the prevention of acute liver damage induced by carbon tetrachloride in rats. J Gastroenterol Hepatol 19 (2004) 333-338
30. Shen Y., Chen C., and Sung Y. Tetrandrine ameliorates ischaemia-reperfusion injury of rat myocardium through inhibition of neutrophil priming and activation. Br J Pharmacol 128 (1999) 1593-1601
31. Vollmar B., Richter S., and Menger M. Liver ischemia/reperfusion induces an increase of microvascular leukocyte flux, but not heterogeneity of leukocyte trafficking. Liver 17 (1997) 93-98
32. Gorur S., Bagdatoglu O., and Polat G. Protective effect of l-carnitine on renal ischaemiareperfusion injury in the rat. Cell Biochem Funct 23 (2005) 151-155
33. Yu B. Cellular defenses against damage from reactive oxygen species [published correction appears in Physiol Rev. 1995;75:preceding 1]. Physiol Rev 74 (1994) 139-162
34. Bykov I., Mal'tsev A., Gurinovich V., and Nefedov L. Biochemical basis of valproic acid toxicity: Role of oxidative stress and effects of l-carnitine [in Russian]. Biomed Khim 50 (2004) 384-389